Skip to main content

Patient groups push back against Gilead's pricey HIV prevention treatment


Interesting story by Deena Beasley

LOS ANGELES (Reuters) - Gilead Sciences Inc (GILD.O) hopes to soon introduce a pricey new pill to prevent HIV in people at risk of contracting the infection, but the drugmaker faces opposition from an unusual source: patient advocates.

Such groups have traditionally lobbied for insurance coverage of newer HIV drugs regardless of expense. But at least three U.S. organizations now question whether Gilead’s Descovy would be the best option for most people at risk of exposure.

A generic version of the current prevention pill, Truvada, is due in the United States next September, which should bring down costs and give many more people access to the therapy, they say.

Their resistance is being echoed by some insurers, including the pharmacy benefit arm of Cigna Inc, which are hinting that price will be a barrier to providing coverage for Descovy.

“Based on the science that we have seen thus far, there is no indication that everyone needs to be taking Descovy,” Tim Horn, director of medication access and pricing at the National Alliance of State and Territorial AIDS Directors (NASTAD) told Reuters.

“We see no reason to push back against commercial payers or Medicaid programs that would move to prefer generic Truvada (for prevention), provided there are guard-rails that do not deny access to Descovy for those who need Descovy,” he said.

Truvada, also made by Gilead, has been used to treat people infected with HIV since 2004. It was approved as a daily pill for pre-exposure prophylaxis, or PrEP, in 2012, and remains the only preventive therapy on the U.S. market.

Descovy, shown to be less toxic than Truvada to the kidneys and bones in clinical trials, was approved in 2016 for people already infected with HIV. Advisors to the U.S. Food and Drug Administration will meet on Wednesday to decide whether to recommend Descovy for PrEP, with agency approval widely expected before the end of the year.

When asked about the patient groups’ criticism, Gilead said Descovy is safer than Truvada and offers more efficient delivery of its antiviral component, resulting in greater concentration of the drug in cells where HIV infection can occur.

The Centers for Disease Control and Prevention estimates that 1.1 million people in the United States could benefit from PrEP. High-risk populations include people having sex with someone who is infected with HIV or who share injection needle equipment. Gilead said 213,000 people were taking Truvada for HIV prevention in the second quarter of this year.

The company has pledged to help the Trump administration achieve a goal of stopping the spread of HIV in the United States within a decade. In May, Gilead said it would donate enough Truvada annually to supply 200,000 uninsured Americans with PrEP until Descovy is approved for HIV prevention, then switch patients to the new drug.

PRICING IMMUNITY

HIV drugmakers have largely been shielded from generic competition. Each time one of their therapies came close to losing patent protection, scientific advances allowed them to introduce a new drug that improved on its predecessor, often with a higher price.

Both Truvada and Descovy are priced at $21,000 per year, before discounts provided to public and private health insurers. In the first half of 2019, Gilead’s Truvada sales totaled $1.32 billion. Descovy sales amounted to $700 million and are expected to rise to $3 billion dollars annually by 2024, according to IBES data from Refinitiv.Teva Pharmaceutical Industries Ltd (TEVA.TA) is due to sell a generic version of Truvada next year. More significant price competition is expected when other generic competitors emerge in 2021.

Some prominent patient advocates, including community-based advocacy organization Treatment Action Group (TAG) and NASTAD, which advocates for public health, told Reuters that Gilead has not proven the newer treatment provides enough of a benefit to justify its use beyond people at risk of kidney or bone density problems. At a time when HIV drug prices are soaring, their views may provide support to health insurers who routinely push generic drug use to curb costs.

Jeremiah Johnson, HIV project director at TAG, told Reuters he is open to a conversation about health plans requiring individuals try a generic drug before using a significantly more expensive regimen like Descovy.

TAG and PrEP4All Collaboration, which aims to expand access to PrEP for all Americans, earlier this year called for the FDA to convene the advisory committee review of Descovy, citing concerns over Gilead’s trial data and pricing practices.

Not all experts are as vocal in questioning Gilead’s aims. Dr. Paul Volberding, director of the AIDS Research Institute at the University of California, San Francisco, told Reuters that Descovy for PrEP should be made available to people that have insurance to pay for it, while a generic could make sense for people with less access to coverage.

“The safety difference is small, but real,” he said.

Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases, told Reuters that Descovy may provide an advantage because it remains in the body for longer than Truvada. “If you miss a dose or two it is unlikely that there is going to be a gap in protection,” he said.

But some health insurers, which largely cover Truvada for PrEP, are not convinced of a significant benefit from Descovy.

“Based on the current information and data available to us at this time, we believe generic Truvada will be the most cost effective option for PrEP,” said David Lassen, chief clinical officer at Prime Therapeutics, which manages pharmacy benefits for Blue Cross Blue Shield health plans.

Express Scripts, the pharmacy benefit manager owned by Cigna, said cost is a big barrier to U.S. use of Truvada for PrEP.

“We would certainly look to leverage cost savings from generic Truvada to help improve affordability for patients and payers,” the company told Reuters.

Comments

Trending

Hacked To Death: Kawere Fahad 21 Years Dies From His Wounds

Driven, young, restless and focused begins to describe Kawere Fahad 21 years.  Rest In Peace!

Wakiso District, in the Central Region of Uganda is very important to Uganda as DC is to USA or Buckingham is to UK. This area has the biggest number of schools per land size, the oldest Basilica in Africa, real estate hub and is the dormitory District for many urbanites in Uganda. It is in this area that one finds such suburbs like Kayunga and Nansana. These suburbs never go to sleep!  One would expect that this metropolitan profile puts it at a place where murder cases are investigated and deterred by police and communities. And that assailants are stopped in their tracks before they delivered a deeply bruising or fatal blow.

But this was not the case for Fahad Kawere.
KGN has learnt that Fahad and a first batch of friends had a meeting which went up to around 2:30 am (1st August 2019). After the meeting, Fahad got a message and told this first batch of friends that he had to go meet another  …

Housing Homeless LGBTIQQ in Uganda; 2017 Christmas Gift!

History of LGBTIQQ Shelters in Uganda 2004-2009
The last time a shelter for LGBTIQQ evicted, disowned and expelled for their orientation or acting queer in Uganda was known to operate was between 2004-2009. This was when Most At Risk Populations' Society In Uganda (MARPS IN UGANDA) run an apartment at Bukesa (within Kampala Capital City Authority), which was let out at a three months single renewable shelter support. This project got so overwhelmed by need but at the same time was targeted it had to close down at a time when the Anti-Homosexuality Bill was being promulgated. By 2009, it had housed 178 persons. 8 were lesbians aged 17 years to 29 years; 70 were Transgender persons aged 16 years-24 years; 50 were identifying as gay aged 18 years-55 years; 50 were identifying as Bisexual, Queer, Questioning and Non-conforming/non-binary. It cost us Uganda shillings 21,500,000 to run the facility between 2004-2009. An addition resource center was opened up in Kawaala (a suburb of Kampa…

Herpes Simplex Virus ( Cold Sores)

What are the symptoms, & how is it diagnosed? The symptoms of herpes depends on the site of disease: Oral herpes (cold sores): Sores around the mouth and nostrils. They may itch or be painful. They might look like the sore in this picture: Genital herpes: Sores on the penis in males or near or in the vagina in women. Genital herpes can also cause sores near the anus, including the area between the anus and the genitals (the perineum). Sometimes, genital herpes can cause pain when urinating or defecation. They might look like the sores in this picture: How is herpes diagnosed? Oral and genital herpes are well-known diseases. Most doctors and other health-care providers know herpes when they see it. In turn, both types of herpes can often be diagnosed—and treatment recommended— simply by examining the sores. However, guidelines published by the Centers for Disease Control and Prevention (CDC) recommends that mouth sores in particular be confirmed by laboratory testing as oral herpes ca…

Kampala, Uganda: We Remember Ivan, 27!

One day, in 2009 a group of friends talked about forming an entertaining chorus or music group. They threw around ideas but we left things to go on a burner as it were. Other issues needed to be dealt with. 12 people had HIV and needed care in form of transport and nutrition support. 24 had housing issues and 170 needed to be part of a social support network in which they could express their needs. Among the members with whom we were discussing was Eric Lubega Ngobi who also goes by the name Ivan.
Fast forward, the year is 2014, a team has just arrived in Kenya and is going through a locational cultural shock. No more familiar places like it was in Uganda! From that time on, it was new culture, new way of doing things, new languages, not many familiar faces. Even the Kenyans who studied in Uganda were distant. Perhaps because this particular group had come out as LGBTIQQ. Friends were far and apart. People relied on handouts and sex work. They also relied on well wishers who never disc…

Why is only one of a gay couple’s twin sons considered a United States citizen?

Jeff Taylor of LGBTQ Nation in September 19th 2017 report, writes that a gay couple is learning the hard way just how complicated United States immigration law can be, especially when it comes to same-sex couples and surrogacy.
Andrew and Elad Dvash-Banks moved to Canada in 2011 in order to get married and begin their lives together, as the United States had yet to legalize marriage equality. They had twins with the help of assisted reproductive technology (ART), using an anonymous egg donor and gestational surrogate, and both of their sperm.
Canada recognized both men as legal parents to the children, naming them both on each child’s birth certificate.
Andrew has dual U.S. and Canadian citizenship, and Elad is an Israeli citizen, and the couple eventually decided to return to the United States, thus kicking off all the troubleAbove The Law reports.
The U.S. Immigration Code ties the right to citizenship to DNA, and only Andrew has citizenship rights he could pass on to his offspring.
Th…

On The verge of Homelessness In a country That is Preparing for Elections, Refugees Are Wondering When the Next Cheque Will Come To Enable Them Pay Rent

About to be evicted for 4 months back rent, refugees sought support from UNHCR (Photo courtesy of Alia Adams)


The landlord, had always been distant, kind, patient and tolerant. It is the wife who sometimes would prepare a Kenyan dish which she shared with the people who rented one of their small 2 bedroom house. She was the face they saw most of the times and she reminded them of all mothers. 
The landlord lives nearby in a bigger 5 bedroom house so it is not uncommon for someone from the landlord’s home to come and ask them for a helping hand or run errands. 
Matasia, Ngong is an exclusive part of Nairobi Capital City. A part of a larger escarpment so many feet above sea level. The climate and rich soils allow the lush green leaved trees to grow to very large sizes. The neighbourhood is considered urban and the roads are paved. It is the serene setting out of glossy magazines. To have this place, they pooled together money they got as allowances to pay for rent. Here…

Kampala Uganda: Top-Bottom Role Peddling Is Sexism And Objectifies LGBTIQQ Defeating The Purpose Of Humanism

The Idea of writing a story of abuse

A friend of mine (Paschal), is on the path to a PhD in Social Work in the UK, and is a mentor who introduced me to a group of Gay writers from Kenya. The friend usually sends me links with a variety of thematic topics or article titles that we both discuss after reading. I find the articles very intriguing always given the fact that they provide another perspective about common issues we talk about regularly. This time around, my friend sent me a link showing how food justice issues can be used to remedy abuses for marginalized communities. It was a classic example of superior-inferior dichotomy; valued humans versus humanoid; Enforcers Vs. Abused and oppressor-oppressed dualism.... See: Food Justice and Sexism. Food justice? Okay, I get it. That moment when one is assured of say housing/shelter, no harassment for who or what they believe in, one gets the right treatment and food security is assured. You get my point?



Advocacy-splaining and how it si…

Hep C

F.D.A. Approves Pill to Treat Hepatitis C Thor Swift for The New York Times Tom Espinosa, a building inspector in Oakland, Calif, has tried the existing drugs for hepatitis C and some experimental ones, without success. By  Published: December 6, 2013FACEBOOKTWITTERGOOGLE+SAVEEMAILSHAREPRINTREPRINTS

HIV Guidelines Make Special HPV Recommendations for Gay Men

Get vaccinated for human papillomavirus (HPV) up until age 40 years of age. Gay and bisexual men with HIV should get vaccinated for human papillomavirus (HPV) up until age 40, according to updated guidelines from the European AIDS Clinical Society (EACS), released this week at the 16th European AIDS Conference. And others with HIV should be vaccinated until age 26, the guidelines state. "We wanted to make a strong point that patients with HIV infection, and gay men in particular, should get vaccinated," said Georg Behrens, MD, PhD, from the Hannover Medical School in Germany, who is chair of the comorbidities subcommittee of the EACS guidelines panel. This differs from the US guidelines, which call for both men and women to be vaccinated for HPV until age 26 if they weren't vaccinated as preteens or teenagers, but make no special recommendations for gay or bisexual men. Emerging data show that HPV-related cancers are growing in prevalence in all people with HIV, includin…

WATCH: Hot Naked Gay Men Jello Wrestling in Sexy, NSFW HIV Testing Ad

Sexy, strong, and healthy seems to be the message. Oh, and naked. BY DIANE ANDERSON-MINSHALL DECEMBER 04 2013 12:59 PM ET 95